Cefotaxime

   
Google
 
Web NewDrugInformation.com

Cefotaxime


Drug - Cefotaxime
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefotaxime Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 10GM BASE/VIAL
The potency of the active ingredient(s), Cefotaxime Sodium. May repeat for multiple part products.

Applicant - AM PHARM PARTNERS
The firm name holding legal responsibility for Cefotaxime. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 064201
The FDA assigned number to Cefotaxime. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cefotaxime. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 24, 2000
The date Cefotaxime was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cefotaxime. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cefotaxime is in. Format is RX, OTC, DISCN.

Applicant Full Name - American Pharmaceutical Partners Inc
The full name of the firm holding legal responsibility for the new application of Cefotaxime.

Cefotaxime